A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction
- PMID: 29405511
- DOI: 10.1002/ejhf.1140
A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction
Abstract
Background: In heart failure (HF), a flattening oxygen consumption (VO2 ) trajectory during cardiopulmonary exercise test (CPET) reflects an acutely compromised cardiac output. We hypothesized that a flattening VO2 trajectory is helpful in phenotyping disease severity and prognosis in HF with either reduced (HFrEF), mid-range (HFmrEF), or preserved (HFpEF) ejection fraction.
Methods and results: Overall, 319 HF patients (198 HFrEF, 80 HFmrEF, and 41 HFpEF) underwent CPET. A flattening VO2 trajectory was tracked and defined as an inflection of VO2 linearity as a function of work rate with a second slope downward inflection >35% extent of the first one. Peak VO2 , the minute ventilation/carbon dioxide production (VE/VCO2 ) slope, and the presence of exercise oscillatory ventilation (EOV) were also determined. Pulmonary artery systolic pressure (PASP) and tricuspid annular plane systolic excursion (TAPSE) were measured by echocardiography. A flattening VO2 occurred in 92 patients (28.8%). PASP and TAPSE at rest were significantly higher and lower (P < 0.001), respectively. The primary outcome was the combination of all-cause death, heart transplantation and left ventricular assist device implantation. The secondary outcome was the primary outcome plus hospitalization for cardiac reasons. In the multivariate model including peak VO2 , VE/VCO2 slope, EOV and VO2 trajectory, a flattening VO2 trajectory and EOV were retained in the regression for primary (X2 = 35.78, and 36.36, respectively; P < 0.001) and secondary (X2 = 12.45 and 47.91, respectively; P < 0.001) outcomes.
Conclusions: Results point to a flattening VO2 trajectory as a likely new and strong predictor of events in HF with any ejection fraction. Given the relation of right-sided cardiac dysfunction to pulmonary hypertension, this oxygen pattern might suggest a real-time decrease in pulmonary blood flow to the left heart.
Keywords: Heart failure with mid-range ejection fraction; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; VO2 flattening.
© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.
Comment in
-
Oxygen consumption trajectory flattening-yet another cardiopulmonary exercise testing parameter in chronic heart failure.Eur J Heart Fail. 2018 Jul;20(7):1125-1127. doi: 10.1002/ejhf.1181. Epub 2018 Apr 14. Eur J Heart Fail. 2018. PMID: 29656493 No abstract available.
Similar articles
-
Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.J Am Heart Assoc. 2017 Oct 31;6(11):e006000. doi: 10.1161/JAHA.117.006000. J Am Heart Assoc. 2017. PMID: 29089342 Free PMC article.
-
Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.Eur J Heart Fail. 2017 Dec;19(12):1664-1671. doi: 10.1002/ejhf.873. Epub 2017 Jun 8. Eur J Heart Fail. 2017. PMID: 28597497
-
Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.Eur J Heart Fail. 2017 Dec;19(12):1675-1685. doi: 10.1002/ejhf.913. Epub 2017 Oct 8. Eur J Heart Fail. 2017. PMID: 28990307 Free PMC article.
-
Effect of Aerobic Exercise on Peak Oxygen Consumption, VE/VCO2 Slope, and Health-Related Quality of Life in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction: a Systematic Review and Meta-Analysis.Curr Atheroscler Rep. 2019 Nov 9;21(11):45. doi: 10.1007/s11883-019-0806-6. Curr Atheroscler Rep. 2019. PMID: 31707525
-
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis.Curr Heart Fail Rep. 2024 Jun;21(3):224-237. doi: 10.1007/s11897-024-00661-1. Epub 2024 Apr 18. Curr Heart Fail Rep. 2024. PMID: 38635117 Free PMC article. Review.
Cited by
-
Invasive Hemodynamic and Metabolic Evaluation of HFpEF.Curr Treat Options Cardiovasc Med. 2021 May;23(5):32. doi: 10.1007/s11936-021-00904-7. Epub 2021 Mar 26. Curr Treat Options Cardiovasc Med. 2021. PMID: 34177247 Free PMC article.
-
The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy.Medicina (Kaunas). 2023 Jul 13;59(7):1296. doi: 10.3390/medicina59071296. Medicina (Kaunas). 2023. PMID: 37512108 Free PMC article. Review.
-
Prognostic value of cardiopulmonary exercise test in patients with acute myocardial infarction after percutaneous coronary intervention.Sci Rep. 2024 Jul 15;14(1):16331. doi: 10.1038/s41598-024-66963-5. Sci Rep. 2024. PMID: 39009689 Free PMC article.
-
Cardiopulmonary assessment of patients diagnosed with Gaucher's disease type I.Mol Genet Genomic Med. 2021 Aug;9(8):e1757. doi: 10.1002/mgg3.1757. Epub 2021 Jul 18. Mol Genet Genomic Med. 2021. PMID: 34275192 Free PMC article.
-
Revisiting and Implementing the Weber and Ventilatory Functional Classifications in Heart Failure by Cardiopulmonary Imaging Phenotyping.J Am Heart Assoc. 2021 Feb;10(5):e018822. doi: 10.1161/JAHA.120.018822. Epub 2021 Feb 20. J Am Heart Assoc. 2021. PMID: 33615821 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous